Лучшие больницы для «Oophorectomy (Ovarian Removal)» в Ченнаи, Индия

The ovaries are paired endocrine and reproductive organs responsible for oogenesis, estrogen and progesterone synthesis, and the regulated hormonal feedback that governs the menstrual cycle, bone density, cardiovascular health, and cognitive function. Pathological conditions including epithelial ovarian carcinoma (EOC), borderline tumors, endometrioma, polycystic ovarian disease refractory to medical management, and benign or malignant adnexal masses may necessitate unilateral oophorectomy (removal of one ovary) or bilateral oophorectomy (removal of both ovaries). When bilateral oophorectomy is performed premenopausally, it induces surgical menopause — an abrupt cessation of ovarian hormone production — producing vasomotor symptoms, accelerated bone loss (osteoporosis risk increases 2–3 fold within five years), elevated cardiovascular risk, and potential cognitive sequelae; meticulous pre-operative counseling and post-operative hormone replacement therapy (HRT) planning are therefore integral to the standard of care.

• CONFIRMED SURGICAL CANDIDATES:
• Women diagnosed with epithelial ovarian carcinoma (EOC), germ cell tumors, or sex cord-stromal tumors requiring surgical staging or debulking
• Patients with BRCA1 or BRCA2 pathogenic variants who have completed childbearing and elect risk-reducing salpingo-oophorectomy (RRSO); recommended between ages 35–40 (BRCA1) and 40–45 (BRCA2) per NCCN guidelines
• Symptomatic endometrioma (≥3 cm) or complex adnexal cysts with malignant features on imaging (elevated CA-125, solid components, internal vascularity on Doppler)
• Recurrent ovarian torsion or torsion with non-viable ovarian tissue confirmed intraoperatively
• +23 more

APPROACH 1 — CONVENTIONAL MULTIPORT LAPAROSCOPIC OOPHORECTOMY The gold-standard minimally invasive technique for benign and selected malignant adnexal disease. Three to four ports (5–12 mm) are placed in the abdomen; the surgeon uses a 10 mm 0° or 30° high-definition laparoscope, monopolar and bipolar energy devices (LigaSure, Harmonic scalpel), and an endoscopic retrieval bag (Endobag) to excise the ovary without spillage of cyst contents — a critical oncologic safety measure. CO₂ pneumoperitoneum is maintained at 12–15 mmHg. Estimated blood loss is typically <100 mL. Operative time: 45–90 minutes. Hospital stay: 1–2 days.

APPROACH 2 — SINGLE-INCISION LAPAROSCOPIC SURGERY (SILS / LESS) A technique where all instruments are introduced through a single 2–3 cm umbilical incision using a multichannel port (e.g., SILS Port, GelPOINT). Offers superior cosmesis (effectively scarless) and equivalent safety compared to multiport laparoscopy in experienced hands. Particularly favored for younger patients undergoing unilateral oophorectomy for benign conditions such as dermoid cysts or endometrioma.

APPROACH 3 — ROBOTIC-ASSISTED LAPAROSCOPIC OOPHORECTOMY (RALO) Performed using the da Vinci Xi Surgical System or CMR Surgical Versius platform. The robotic approach provides 10x magnified three-dimensional (3D-HD) visualization, EndoWrist instrumentation with 7 degrees of freedom, and tremor filtration — enabling precise dissection in deep or narrow pelvic spaces, superior control at the infundibulopelvic ligament, and reduced risk of inadvertent ureteral or vascular injury. Particularly advantageous in cases with dense adhesions from prior endometriosis, previous pelvic surgery, or in patients with a BMI >35. Operative time: 60–120 minutes. Hospital stay: 1–2 days. Available at flagship centers in Mumbai, Chennai, Gurugram (India) and Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai (UAE).

APPROACH 4 — OPEN (LAPAROTOMY) OOPHORECTOMY Indicated for advanced-stage ovarian malignancy requiring cytoreductive surgery, cases where laparoscopic conversion is necessitated intraoperatively (hemorrhage, dense adhesions, failed visualization), or when oophorectomy is performed as a component of radical hysterectomy with pelvic lymph node dissection. A vertical midline or Pfannenstiel incision is made; the surgeon performs meticulous dissection of the ovarian pedicles, securing the infundibulopelvic (IP) ligament and utero-ovarian ligament with absorbable sutures or surgical staplers. Estimated blood loss: 150–500 mL. Hospital stay: 3–5 days. Recovery: 4–6 weeks.

PHASE 1 — INITIAL CONSULTATION & PRE-TRAVEL PREPARATION (2–4 weeks before travel)

• Submit medical records, imaging (TVUS, MRI, PET-CT), and tumor marker results to GAF Healthcare's medical coordination team
• Receive a formal Second Opinion Report from the assigned gynecologic surgeon within 48–72 hours
• Finalize treatment plan (laparoscopic vs. robotic vs. open; unilateral vs. bilateral), surgical date, and destination (India or UAE)
• Complete required blood tests, cardiac clearance (ECG/ECHO), and anesthesia risk assessment — these may be performed locally and submitted digitally, or completed upon arrival
• Genetic counseling appointment scheduled if BRCA testing is indicated
• For premenopausal patients undergoing bilateral oophorectomy: fertility preservation consultation and cryopreservation arranged if desired
• GAF Healthcare initiates e-Medical visa application for India (typically approved within 1–3 business days) or confirms UAE entry requirements
• Pre-operative bowel preparation instructions and medication adjustments (anticoagulants, NSAIDs, hormone therapy) communicated by surgical team

PHASE 2 — ARRIVAL & PRE-OPERATIVE WORKUP (Day 1–2 in country)